Parexel Releases Proprietary Biotech Market Research Report to Help Guide Companies on Navigating the Biotech Investment Landscape
January 06, 2022 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel
November 15, 2021 17:03 ET
|
Parexel International LLC
EQT Private Equity and Goldman Sachs Asset Management committed to supporting Parexel’s Patients-First focus, track record of clinical excellence and dedication to qualityNewly-appointed Board of...
Parexel and Kyoto University Hospital Announce Strategic Alliance
October 20, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment
October 04, 2021 08:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel’s Peyton Howell and Sofia Baig Named to 2021 PharmaVOICE 100
August 02, 2021 08:00 ET
|
Parexel International LLC
Parexel leaders recognized as two of the 100 most inspiring people in life sciences for their transformative efforts to drive equity and innovation across the industry BOSTON and DURHAM, N.C., Aug. ...
Parexel Announces Innovative Patient Centric Partnership with Cancer Hospital Chinese Academy of Medical Sciences
July 28, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
July 22, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Expands Asia/Pacific Capability through Enhanced Clinical Trial Supplies and Logistics Offering
July 07, 2021 08:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel, EQT Private Equity와Goldman Sachs Asset Management가 인수
July 06, 2021 14:52 ET
|
Parexel International LLC
보스턴, 노스캐롤라이나주 더럼, July 07, 2021 (GLOBE NEWSWIRE) -- 환자 건강 증진을 위한 혁신적인 신약 개발 및 공급에 중점을 두고 있는 글로벌 CRO(임상시험수탁기관)인 Parexel은 EQT IX 펀드(“EQT Private Equity”)와 Goldman Sachs Asset Management...
Parexel s'apprête à être acquise par EQT Private Equity et Goldman Sachs Asset Management
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON et DURHAM, Caroline du Nord, 06 juill. 2021 (GLOBE NEWSWIRE) -- Parexel, une organisation de recherche clinique (CRO) de premier plan à l'échelle mondiale axée sur le développement et la...